We read with much interest the recent letter on buccal midazolam by Hindley and Jameson.¹

The main reason that some recommend a buccal midazolam test dose is concern about the risk of an adverse reaction, particularly respiratory depression or apnoea, especially should it occur outside hospital. However, there is evidence that buccal midazolam is more effective than rectal diazepam and is not associated with an increased incidence of respiratory depression.²

We recently undertook a survey of epilepsy nurse specialists. Thirty questionnaires were sent to …